Stock Events

Stock Events

BioCardia 

$1.0700
40
-$0.02-1.83% 11:03 Today

Statistics

Day High
1.1
Day Low
1.09
52W High
2.29
52W Low
0.75
Volume
10,805
Avg. Volume
-
Mkt Cap
16.5M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

11NovExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Q2 2026
Next
-0.63
-0.44
-0.25
-0.06
Expected EPS
-0.13
Actual EPS
N/A

Financials

-Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
0Revenue
-8.23MNet Income

Analyst Ratings

25.00Average Price Target
The highest estimate is 25.00.
From 1 ratings within the last 6 months. This is not an investment recommendation.
Buy
100%
Hold
0%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow BCDA. It's not an investment recommendation.
Apple
9
AAPL
Amazon
7
AMZN
NVIDIA
7
NVDA
Palantir Technologies
7
PLTR

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Medtronic
MDT
Mkt Cap116.77B
Medtronic operates in the cardiovascular space, offering products that compete directly with BioCardia's heart disease treatments.
Abbott Laboratories
ABT
Mkt Cap194.62B
Abbott Laboratories provides a wide range of medical devices, including those for cardiovascular health, directly competing with BioCardia's offerings.
Boston Scientific
BSX
Mkt Cap67.88B
Boston Scientific Corporation specializes in medical devices for various conditions, including cardiovascular, making it a direct competitor.
Edwards Lifesciences
EW
Mkt Cap52B
Edwards Lifesciences focuses on heart valves and hemodynamic monitoring, competing in the cardiovascular space with BioCardia.
Intuitive Surgical
ISRG
Mkt Cap131.63B
Intuitive Surgical offers robotic-assisted surgical systems that can be used in cardiovascular procedures, indirectly competing with BioCardia's treatments.
Baxter International
BAX
Mkt Cap13.51B
Baxter International Inc. provides a range of medical devices and therapies, including for cardiovascular diseases, competing with BioCardia.
Zimmer Biomet
ZBH
Mkt Cap19.25B
Zimmer Biomet Holdings, Inc., while primarily focused on musculoskeletal healthcare, has expanded into new areas, potentially competing with BioCardia.
Stryker
SYK
Mkt Cap126.84B
Stryker Corporation, known for medical and surgical equipment, has products that can be used in cardiovascular care, making it a competitor.
Johnson & Johnson
JNJ
Mkt Cap645.95B
Johnson & Johnson, through its medical devices segment, offers products that can compete in the cardiovascular space with BioCardia.
Integra Lifesciences
IART
Mkt Cap1.31B
Integra LifeSciences, a provider of regenerative technologies, could compete in the cardiovascular and wound care markets relevant to BioCardia.

About

BioCardia Inc is a clinical-stage company developing cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases with unmet medical needs. Its two cell therapy platforms derived from the bone marrow. CardiAMP autologous mononuclear cell therapy platform is being for two clinical indications: ischemic heart failure with reduced ejection fraction (HFrEF) and refractory angina resulting from chronic myocardial ischemia (CMI). Its immunomodulatory allogeneic mesenchymal stem cell (MSC) therapy platform is being an off the shelf cell therapy for two clinical indications: the treatment of ischemic HFrEF (CardiALLO), which is actively enrolling, and acute respiratory distress syndrome (ARDS).
Show more...
CEO
Peter A. Altman
Employees
21
Country
United States
ISIN
US09060U6064
WKN
000A40D1S

Listings

MU
DE
6JU0.MU
XNAS
US
BCDA
STU
DE
6JU0.STU
STU
DE
6JU.STU

0 Comments

Share your thoughts

FAQ

What is BioCardia stock price today?▼
The current price of BCDA is $1.07 USD — it has decreased by -1.83% in the past 24 hours. Watch BioCardia stock price performance more closely on the chart.
What is BioCardia stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange BioCardia stocks are traded under the ticker BCDA.
Is BioCardia stock price growing?▼
BCDA stock has fallen by -5.22% compared to the previous week, the month change is a +19.75% rise, over the last year BioCardia has showed a -46.57% decrease.
What is BioCardia market cap?▼
Today BioCardia has the market capitalization of 16.5M
When is the next BioCardia earnings date?▼
BioCardia is going to release the next earnings report on November 11, 2026.
What were BioCardia earnings last quarter?▼
BCDA earnings for the last quarter are -0.13 USD per share, whereas the estimation was -0.18 USD resulting in a +27.78% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is BioCardia revenue for the last year?▼
BioCardia revenue for the last year amounts to 0 USD.
What is BioCardia net income for the last year?▼
BCDA net income for the last year is -8.23M USD.
How many employees does BioCardia have?▼
As of September 04, 2026, the company has 21 employees.
In which sector is BioCardia located?▼
BioCardia operates in the Health & Wellness sector.
When did BioCardia complete a stock split?▼
The last stock split for BioCardia was on May 30, 2024 with a ratio of 1:15.
Where is BioCardia headquartered?▼
BioCardia is headquartered in SUNNYVALE, United States.